Actos Overdosage & Contraindications - Pioglitazone

[Pioglitazone]

ACTOS is contraindicated in patients with known hypersensitivity to this product or any of its components.

OVERDOSAGE

During controlled clinical trials, one case of overdose with ACTOS was reported. A male patient took 120 mg per day for four days, then 180 mg per day for seven days. The patient denied any clinical symptoms during this period. In the event of overdosage, appropriate supportive treatment should be initiated accord-ing to patient's clinical signs and symptoms.